Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04616196 |
| Title | A Phase 1b/2 Study of NKTR 255 in Combination With Cetuximab in Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Nektar Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Diego | San Diego | California | 92103 | United States | Details | |
| University of California, San Francisco | San Francisco | California | 94158 | United States | Details | |
| University of Minnesota | Minneapolis | Minnesota | 55455 | United States | Details | |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| START Center for Cancer Care | San Antonio | Texas | 78229 | United States | Details |